Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action?
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Mesenchymal stromal cells (MSCs) have been found to be safe and effective in a wide range of animal models of human disease. MSCs have been tested in thousands of clinical trials, but results show that while these cells appear to be safe, they tend to lack efficacy. This has raised questions about whether animal models are useful for predicting efficacy in patients. However, a problem with animal studies is that there is a lack of standardisation in the models and MSC therapy regimes used; there appears to be publication bias towards studies reporting positive outcomes; and the reproducibility of results from animal experiments tends not to be confirmed prior to clinical translation. A further problem is that while some progress has been made towards investigating the mechanisms of action (MoA) of MSCs, we still fail to understand how they work. To make progress, it is important to ensure that prior to clinical translation, the beneficial effects of MSCs in animal studies are real and can be repeated by independent research groups. We also need to understand the MoA of MSCs to assess whether their effects are likely to be beneficial across different species. In this review, we give an overview of the current clinical picture of MSC therapies and discuss what we have learned from animal studies. We also give a comprehensive update of what we know about the MoA of MSCs, particularly in relation to their role in immunomodulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In many clinical trials, MSCs have shown little benefit [1, 5, 9].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Mesenchymal stem cell perspective: cell biology to clinical progress
Pittenger, M. F., Discher, D. E., Péault, B. M., Phinney, D. G., Hare, J. M., & Caplan, A. I. (2019) · npj Regenerative Medicine · doi:10.1038/s41536-019-0083-6 · Cited by 2,008
Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.
Friedenstein, A. J., Kv, P., KUROLESOVA, A. I., & Frolova, G. P. (1968) · PubMed · Cited by 1,921
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
HETEROTOPIC TRANSPLANTS OF BONE MARROW
FRIEDENSTEIN, A. J., PETRAKOVA, K. V., KUROLESOVA, A. I., & FROLOVA, G. P. (1968) · Transplantation · doi:10.1097/00007890-196803000-00009 · Cited by 1,699
Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord
Wang, H., Hung, S., Peng, S., Huang, C., Wei, H., Guo, Y., Fu, Y., Lai, M., & Chen, C. (2004) · STEM CELLS · doi:10.1634/stemcells.2004-0013 · Cited by 1,378
Cited by
Calcat-i-Cervera, S., Rendra, E., Scaccia, E., Amadeo, F., Hanson, V., Wilm, B., Murray, P., O’Brien, T., Taylor, A., & Bieback, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03352-1 · Cited by 56
“In many clinical trials, MSCs have shown little benefit [1, 5, 9].”
BackgroundSelf-citationKirkham, A. M., Bailey, A. J.-M., Shorr, R., Lalu, M. M., Fergusson, D. A., & Allan, D. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.10.003 · Cited by 23
Liver Disease and Cell Therapy: Advances Made and Remaining Challenges
Khan, S., Mahgoub, S., Fallatah, N. A., Lalor, P. F., & Newsome, P. N. (2023) · Stem Cells · doi:10.1093/stmcls/sxad029 · Cited by 18
Braga, C. L., Santos, R. T., da Silva, C. M., Rocha, N. N., Felix, N. S., Medeiros, M., Melo, M. M., Silva, J. D., Teixeira¹, D. E., Caruso‐Neves, C., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121988 · Cited by 18
Işıldar, B., Özkan, S., & Koyutürk, M. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300216 · Cited by 14
Niebergall‐Roth, E., & Kluth, M. A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06807-6 · Cited by 13
Amadeo, F., Hanson, V., Murray, P. A., & Taylor, A. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00549-2 · Cited by 12
Self-citationProtective potential of BM-MSC extracted Exosomes in a rat model of Alzheimer’s disease
Sadeghi, A., Noorbakhshnia, M., & Khodashenas, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320883 · Cited by 9
Muñiz-García, A., Pichardo, A. H., Littlewood, J., Tasker, S., Sharkey, J. W., Wilm, B., Peace, H., O'Callaghan, D. W., Green, M., Taylor, A., et al. (2023) · Nanoscale Advances · doi:10.1039/d3na00546a · Cited by 7
Self-citationEvaluation of Cytotoxicity and Bioimaging of Nitrogen-Vacancy Nanodiamonds
Fryer, C., Murray, P. A., & Zhang, H. (2022) · Nanomaterials · doi:10.3390/nano12234196 · Cited by 5
Self-citationHussain, Z. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100563 · Cited by 3
de Pedro, M. A., Pulido, M., Marchena, A. M., Álvarez, V., González-Nuño, F. M., Szymanski, W. G., Pörschke, J., Reinartz, S., Graumann, J., von Strandmann, E. P., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1691010 · Cited by 2
Pulmonary Arterial Hypertension and Endothelial Dysfunction
Onofre, M. E. D. S. F., Santos, R. T., Cruz, F. F., Rocco, P. R. M., & Silva, P. L. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_806 · Cited by 1
Current Progress in Mesenchymal Stromal Cell Therapies
Al‐Anazi, K. A. (2025) · Journal of Regenerative Medicine and Biology Research · doi:10.46889/jrmbr.2025.6202 · Cited by 1
Calcat-i-Cervera, S., Rendra, E., Scaccia, E., Amadeo, F., Hanson, V., Wilm, B., Murray, P., O’Brien, T., Taylor, A., & Bieback, K. (2023) · Figshare · doi:10.6084/m9.figshare.22767212
Self-citationMesenchymal stem cells: towering ambitions, shaky foundations
Cyranoski, D., Turner, L. G., & Sipp, D. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.10.002
Trivino-Cepeda, K., Amadeo, F., Hughes, D. M., Ressel, L., García‐Fiñana, M., Hanson, V., Taylor, A., Murray, P. A., & Wilm, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.19.733188
Self-citationJohnson, W. E. B. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210264
Metadata
- Authors
- Amadeo, F., Trivino Cepeda, K., Littlewood, J., Wilm, B., Taylor, A., & Murray, P.
- Affiliations
- University of Liverpool (GB)
- Department of Molecular Physiology and Cell Signalling, Integrative Biology, University of Liverpool, Crown Street, L69 3GE Liverpool, U.K.
- Corresponding author
- Murray, Patricia
- Venue
- Emerging Topics in Life Sciences
- Publisher
- Portland Press Ltd.
- Published
- 2021-09-08
- Volume
- 5
- Issue
- 4
- Pages
- 549-562
- ISSN
- 2397-8554 (ISSN-L)
- 2397-8562
- PMC
- PMC8589440
- OpenAlex
- W3196765138
- Cited by
- 20
- References
- 125
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 7 · 2022: 4 · 2021: 1
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Emerging Topics in Life Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Commission (HORIZON2020, 813839)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- mesenchymal stem cells, cell therapy, mechanism of action, immunomodulation, animal models, clinical translation, reproducibility, publication bias, treatment efficacy, translational research
- MeSH terms
- Animals, Humans, Immunity, Reproducibility of Results, Mesenchymal Stem Cell Transplantation, Immunomodulation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.